These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 7872723)
1. Characterization of p53 gene mutations in colorectal carcinomas from an Asian population. Shi CY; Phang TW; Ngoi SS; Wee A; Li B; Lin Y; Lee HP; Ong CN Anticancer Res; 1994; 14(6B):2811-6. PubMed ID: 7872723 [TBL] [Abstract][Full Text] [Related]
2. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer. Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965 [TBL] [Abstract][Full Text] [Related]
3. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Kastrinakis WV; Ramchurren N; Rieger KM; Hess DT; Loda M; Steele G; Summerhayes IC Oncogene; 1995 Aug; 11(4):647-52. PubMed ID: 7651727 [TBL] [Abstract][Full Text] [Related]
4. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983 [TBL] [Abstract][Full Text] [Related]
5. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
6. Epidemiological study of p53 tumor suppressor gene mutations in patients from Luxembourg and the German Saar region with an advanced colorectal cancer using PCR-SSCP analysis. Pauly M; Schmitz M; Kayser I; Lagoda P; Türeci O; Kerschen A; Weber J; Seitz G; Hentges F; Dicato M Biomed Pharmacother; 1998; 52(5):220-8. PubMed ID: 9755819 [TBL] [Abstract][Full Text] [Related]
7. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
8. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781 [TBL] [Abstract][Full Text] [Related]
9. Discordance of p53 mutations of synchronous colorectal carcinomas. Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269 [TBL] [Abstract][Full Text] [Related]
10. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene. Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735 [TBL] [Abstract][Full Text] [Related]
11. Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas. Chaves AC; Cherubini K; Herter N; Furian R; Santos DS; Squier C; Domann FE Int J Oncol; 2004 Feb; 24(2):295-303. PubMed ID: 14719105 [TBL] [Abstract][Full Text] [Related]
12. [Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer]. Castagnaro M; Yandell DW; Dockhorn-Dworniczak B; Wolfe HJ; Poremba C Verh Dtsch Ges Pathol; 1993; 77():119-23. PubMed ID: 7511268 [TBL] [Abstract][Full Text] [Related]
13. Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters. Tullo A; D'Erchia AM; Honda K; Mitry RR; Kelly MD; Habib NA; Saccone C; Sbisà E Clin Cancer Res; 1999 Nov; 5(11):3523-8. PubMed ID: 10589767 [TBL] [Abstract][Full Text] [Related]
14. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas. Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192 [TBL] [Abstract][Full Text] [Related]
15. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663 [TBL] [Abstract][Full Text] [Related]
16. p53 alterations are associated with improved prognosis in distal colonic carcinomas. Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825 [TBL] [Abstract][Full Text] [Related]
17. [p53 gene point mutation in human colorectal carcinoma]. Xu W; Yang D; Wan Y Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):328-31. PubMed ID: 8697967 [TBL] [Abstract][Full Text] [Related]
18. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Eguchi S; Kohara N; Komuta K; Kanematsu T Cancer; 1996 Apr; 77(8 Suppl):1707-10. PubMed ID: 8608566 [TBL] [Abstract][Full Text] [Related]
19. Absence of p53 gene mutations in primary neuroblastomas. Vogan K; Bernstein M; Leclerc JM; Brisson L; Brossard J; Brodeur GM; Pelletier J; Gros P Cancer Res; 1993 Nov; 53(21):5269-73. PubMed ID: 8221661 [TBL] [Abstract][Full Text] [Related]
20. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Li YJ; Laurent-Puig P; Salmon RJ; Thomas G; Hamelin R Oncogene; 1995 Feb; 10(3):599-601. PubMed ID: 7845685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]